RaySearch Laboratories AB's quarterly market cap
increased
from Sep. 2023 (kr2,842 Mil) to Dec. 2023 (kr3,096 Mil) and
increased
from Dec. 2023 (kr3,096 Mil) to Mar. 2024 (kr3,943 Mil).
RaySearch Laboratories AB's annual market cap
increased
from Dec. 2021 (kr1,937 Mil) to Dec. 2022 (kr2,331 Mil) and
increased
from Dec. 2022 (kr2,331 Mil) to Dec. 2023 (kr3,096 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. RaySearch Laboratories AB's Enterprise Value for Today is kr4,940 Mil.
RaySearch Laboratories AB Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of RaySearch Laboratories AB's Market Cap
For the Health Information Services subindustry, RaySearch Laboratories AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RaySearch Laboratories AB's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Market Cap distribution charts can be found below:
* The bar in red indicates where RaySearch Laboratories AB's Market Cap falls into.
RaySearch Laboratories AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB (OSTO:RAY B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
RaySearch Laboratories AB Market Cap Related Terms
Thank you for viewing the detailed overview of RaySearch Laboratories AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
RaySearch Laboratories AB (OSTO:RAY B) Business Description
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:RAY B has been successfully added to your 